GemPharmatech Co (SHSE:688046) ROE % Adjusted to Book Value : 1.44% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co ROE % Adjusted to Book Value?

GemPharmatech Co's ROE % for the quarter that ended in Sep. 2024 was 4.13%. GemPharmatech Co's PB Ratio for the quarter that ended in Sep. 2024 was 2.86. GemPharmatech Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 1.44%.

GemPharmatech Co ROE % Adjusted to Book Value Historical Data

The historical data trend for GemPharmatech Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co ROE % Adjusted to Book Value Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.39

1.99

GemPharmatech Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial														2.29	2.01	2.24	4.46	1.44

Competitive Comparison of GemPharmatech Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, GemPharmatech Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemPharmatech Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's ROE % Adjusted to Book Value falls into.

Save Embed

GemPharmatech Co ROE % Adjusted to Book Value Calculation

GemPharmatech Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	7.75%	/	3.89
	=	1.99%

GemPharmatech Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.13%	/	2.86
	=	1.44%

GemPharmatech Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

GemPharmatech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co Headlines

No Headlines